UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Le sujet et le handicap : accompagnement neuropsychologique et psychologique à long terme d’enfants atteints de cancer

Psycho-oncologie, 2020-09, Vol.14 (3), p.137-143

2020

Volltextzugriff (PDF)

La distraction pendant les soins, pensée par les parents d’enfants pris en charge en oncologie

Psycho-oncologie, 2022-12, Vol.16 (4), p.359-364

2022

Volltextzugriff (PDF)

Expression of miR-487b and miR-410 encoded by 14q32.31 locus is a prognostic marker in neuroblastoma

British journal of cancer, 2011-10, Vol.105 (9), p.1352-1361

2011

Volltextzugriff (PDF)

Busulfan pharmacokinetics following intravenous and oral dosing regimens in children receiving high-dose myeloablative chemotherapy for high-risk neuroblastoma as part of the HR-NBL-1/SIOPEN trial

European journal of cancer (1990), 2012-11, Vol.48 (16), p.3063-3072

2012

Volltextzugriff (PDF)

Prognostic Factors for Death Due to Invasive Aspergillosis after Hematopoietic Stem Cell Transplantation: A 1-Year Retrospective Study of Consecutive Patients at French Transplantation Centers

Clinical infectious diseases, 2006-04, Vol.42 (7), p.955-963

2006

Volltextzugriff (PDF)

Pédiatrie nucléaire : applications en oncologie

Médecine nucléaire (Paris), 2012-03, Vol.36 (3), p.146-153

2012

Volltextzugriff (PDF)

Risk factors for hepatic veno-occlusive disease: a retrospective unicentric study in 116 children autografted after a high-dose BU-thiotepa regimen

Bone marrow transplantation (Basingstoke), 2008-10, Vol.42 (7), p.449-454

2008

Volltextzugriff (PDF)

Central nervous system relapse in high-risk stage 4 neuroblastoma: The HR-NBL1/SIOPEN trial experience

European journal of cancer (1990), 2021-02, Vol.144, p.1-8

2021

Volltextzugriff (PDF)

Tandem high-dose chemotherapy with thiotepa and busulfan–melphalan and autologous stem cell transplantation in very high-risk neuroblastoma patients

Bone marrow transplantation (Basingstoke), 2016-02, Vol.51 (2), p.227-231

2016

Volltextzugriff (PDF)

Les tumeurs cardiaques primitives malignes de l’enfant et de l’adolescent

Archives de pédiatrie : organe officiel de la Société française de pédiatrie, 2010-05, Vol.17 (5), p.495-501

2010

Volltextzugriff (PDF)

Tandem high-dose chemotherapy strategy as first-line treatment of primary disseminated multifocal Ewing sarcomas in children, adolescents and young adults

Bone marrow transplantation (Basingstoke), 2015-08, Vol.50 (8), p.1083-1088

2015

Volltextzugriff (PDF)

Malignant ovarian tumors in childhood

Archives de pédiatrie : organe officiel de la Société française de pédiatrie, 2008-06, Vol.15 (5), p.781-782

2008

Volltextzugriff (PDF)

Treatment of children over the age of one year with unresectable localised neuroblastoma without MYCN amplification: Results of the SIOPEN study

European journal of cancer (1990), 2013-11, Vol.49 (17), p.3671-3679

2013

Volltextzugriff (PDF)

Les tumeurs malignes de l’ovaire en pédiatrie

Archives de pédiatrie (Paris), 2008-06, Vol.15 (5), p.781-782

2008

Volltextzugriff (PDF)

Ovarian function after autologous bone marrow transplantation in childhood : high-dose busulfan is a major cause of ovarian failure

Bone marrow transplantation (Basingstoke), 1998-11, Vol.22 (10), p.989-994

1998

Volltextzugriff (PDF)

Busulfan–melphalan in high-risk neuroblastoma: the 30-year experience of a single institution

Bone marrow transplantation (Basingstoke), 2016-08, Vol.51 (8), p.1076-1081

2016

Volltextzugriff (PDF)

Busulfan–Melphalan followed by autologous stem cell transplantation in patients with high-risk neuroblastoma or Ewing sarcoma: an exposed–unexposed study evaluating the clinical impact of the order of drug administration

Bone marrow transplantation (Basingstoke), 2016-09, Vol.51 (9), p.1265-1267

2016

Volltextzugriff (PDF)

Diffuse intrinsic pontine gliomas (DIPG) at recurrence: is there a window to test new therapies in some patients?

Journal of neuro-oncology, 2018-03, Vol.137 (1), p.111-118

2018

Volltextzugriff (PDF)

Elevated Plasma Ferritin and Busulfan Pharmacodynamics During High-dose Chemotherapy Regimens in Children with Malignant Solid Tumors

Clinical pharmacology and therapeutics, 2007-10, Vol.82 (4), p.402-409

2007

Volltextzugriff (PDF)

Assessment of executive functioning in children and young adults treated for frontal lobe tumours using ecologically valid tests

Neuropsychological rehabilitation, 2016-07, Vol.26 (4), p.558-583

2016

Volltextzugriff (PDF)

Place of Brachytherapy as Part of the Multimodal Treatment of Pediatric Bladder-Neck and/or Prostate Rhabdomyosarcoma

International journal of radiation oncology, biology, physics, 2016-10, Vol.96 (2), p.S119-S119

2016

Volltextzugriff (PDF)

Fibrose rétropéritonéale et lymphome chez un enfant de 15 ans

Archives de pédiatrie : organe officiel de la Société française de pédiatrie, 2008, Vol.15 (12), p.1756-1759

2008

Volltextzugriff (PDF)

Treatment-related cardiotoxicity in childhood cancer survivors: Risk factors and follow-up

La revue de medecine interne, 2017-02, Vol.38 (2), p.125

2017

Volltextzugriff (PDF)

Prospective validation of a novel IV busulfan fixed dosing for paediatric patients to improve therapeutic AUC targeting without drug monitoring

Cancer chemotherapy and pharmacology, 2008-01, Vol.61 (1), p.113-123

2008

Volltextzugriff (PDF)

Chromosomal CGH identifies patients with a higher risk of relapse in neuroblastoma without MYCN amplification

British journal of cancer, 2007-07, Vol.97 (2), p.238-246

2007

Volltextzugriff (PDF)

1 – 25 von 222

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(204)
Mit Volltextzugriff
(181)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(114)
Science & Technology
(102)
Life Sciences & Biomedicine
(101)
Child
(88)
Oncology
(82)
Male
(73)
Female
(72)
Child, Preschool
(67)
Infant
(66)
Adolescent
(57)
Biological And Medical Sciences
(56)
Medical Sciences
(56)
Neuroblastoma
(43)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(36)
Risk Factors
(31)
Tumors
(31)
Hematology
(30)
Prognosis
(29)
Chemotherapy
(28)
Pediatrics
(27)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Le sujet et le handicap : accompagnement neuropsychologique et psychologique à long terme d’enfants atteints de cancer

La distraction pendant les soins, pensée par les parents d’enfants pris en charge en oncologie

Expression of miR-487b and miR-410 encoded by 14q32.31 locus is a prognostic marker in neuroblastoma

Busulfan pharmacokinetics following intravenous and oral dosing regimens in children receiving high-dose myeloablative chemotherapy for high-risk neuroblastoma as part of the HR-NBL-1/SIOPEN trial

Prognostic Factors for Death Due to Invasive Aspergillosis after Hematopoietic Stem Cell Transplantation: A 1-Year Retrospective Study of Consecutive Patients at French Transplantation Centers

Pédiatrie nucléaire : applications en oncologie

Risk factors for hepatic veno-occlusive disease: a retrospective unicentric study in 116 children autografted after a high-dose BU-thiotepa regimen

Central nervous system relapse in high-risk stage 4 neuroblastoma: The HR-NBL1/SIOPEN trial experience

Tandem high-dose chemotherapy with thiotepa and busulfan–melphalan and autologous stem cell transplantation in very high-risk neuroblastoma patients

Les tumeurs cardiaques primitives malignes de l’enfant et de l’adolescent

Tandem high-dose chemotherapy strategy as first-line treatment of primary disseminated multifocal Ewing sarcomas in children, adolescents and young adults

Malignant ovarian tumors in childhood

Treatment of children over the age of one year with unresectable localised neuroblastoma without MYCN amplification: Results of the SIOPEN study

Les tumeurs malignes de l’ovaire en pédiatrie

Ovarian function after autologous bone marrow transplantation in childhood : high-dose busulfan is a major cause of ovarian failure

Busulfan–melphalan in high-risk neuroblastoma: the 30-year experience of a single institution

Busulfan–Melphalan followed by autologous stem cell transplantation in patients with high-risk neuroblastoma or Ewing sarcoma: an exposed–unexposed study evaluating the clinical impact of the order of drug administration

Diffuse intrinsic pontine gliomas (DIPG) at recurrence: is there a window to test new therapies in some patients?

Elevated Plasma Ferritin and Busulfan Pharmacodynamics During High-dose Chemotherapy Regimens in Children with Malignant Solid Tumors

Assessment of executive functioning in children and young adults treated for frontal lobe tumours using ecologically valid tests

Place of Brachytherapy as Part of the Multimodal Treatment of Pediatric Bladder-Neck and/or Prostate Rhabdomyosarcoma

Fibrose rétropéritonéale et lymphome chez un enfant de 15 ans

Treatment-related cardiotoxicity in childhood cancer survivors: Risk factors and follow-up

Prospective validation of a novel IV busulfan fixed dosing for paediatric patients to improve therapeutic AUC targeting without drug monitoring

Chromosomal CGH identifies patients with a higher risk of relapse in neuroblastoma without MYCN amplification

Suchergebnisse filtern